Journal article icon

Journal article

Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.

Abstract:

BACKGROUND: The aim of chemotherapy in patients with platinum resistant ovarian cancer is palliation. Patients' experience of symptoms is not well documented, and the impact of treatment on symptoms has not been evaluated in clinical trials. We report symptom burden and treatment outcomes from stage 1 of the Gynecological Cancer Intergroup (GCIG) Symptom Benefit Study. METHODS: One hundred twenty-six patients receiving palliative chemotherapy completed 5 validated health-related quality-of-li...

Expand abstract

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
Expand authors...
Publisher:
Lippincott Williams and Wilkins
Journal:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Volume:
24
Issue:
5
Pages:
857-864
Publication date:
2014-06-01
DOI:
EISSN:
1525-1438
ISSN:
1048-891X
Source identifiers:
466376

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP